Loading...
XSTO
ALIF B
Market cap13bUSD
Mar 31, Last price  
144.90
1D
-1.63%
1Q
5.54%
Jan 2017
342.05%
IPO
510.00%
Name

AddLife AB

Chart & Performance

D1W1MN
P/E
P/S
EPS
2.14
Div Yield, %
0.69%
Shrs. gr., 5y
1.83%
Rev. gr., 5y
24.21%
Revenues
10.29b
+6.21%
906,500,000983,500,0001,722,600,0001,562,400,0001,938,300,0002,333,300,0002,481,600,0003,479,400,0005,273,300,0007,992,600,0009,084,000,0009,685,000,00010,286,000,000
Net income
252m
+32.63%
73,800,00078,000,000102,000,00077,800,000111,800,000120,300,000129,300,000140,600,000517,800,000719,000,000480,000,000190,000,000252,000,000
CFO
1.10b
+41.66%
118,600,00091,600,000120,400,000117,700,000132,900,000208,000,000177,500,000400,400,000950,100,0001,010,200,000909,000,000773,000,0001,095,000,000
Dividend
May 09, 20250.75 /sh
Earnings
Apr 25, 2025

Profile

AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments. This segment also offers support, maintenance, advice, and training services. The Medtech segment provides medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, fall prevention, welfare technology, ear, and nose and throat segments, as well as bathroom-related assistive devices and assistive devices for children with disabilities. It operates in Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
IPO date
Mar 16, 2015
Employees
2,296
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122016‑03
Income
Revenues
10,286,000
6.21%
9,685,000
6.62%
9,084,000
13.66%
Cost of revenue
9,587,000
9,319,000
8,405,000
Unusual Expense (Income)
NOPBT
699,000
366,000
679,000
NOPBT Margin
6.80%
3.78%
7.47%
Operating Taxes
151,000
147,000
119,000
Tax Rate
21.60%
40.16%
17.53%
NOPAT
548,000
219,000
560,000
Net income
252,000
32.63%
190,000
-60.42%
480,000
-33.24%
Dividends
(61,000)
(146,000)
(243,000)
Dividend yield
Proceeds from repurchase of equity
(12,000)
(9,000)
(27,000)
BB yield
Debt
Debt current
2,403,000
2,622,000
Long-term debt
3,390,000
3,325,000
Deferred revenue
Other long-term liabilities
4,561,000
179,000
202,000
Net debt
(331,000)
5,512,000
5,467,000
Cash flow
Cash from operating activities
1,095,000
773,000
909,000
CAPEX
(226,000)
(282,000)
Cash from investing activities
(386,000)
(317,000)
(1,086,000)
Cash from financing activities
(682,000)
(554,000)
134,000
FCF
1,501,000
(33,000)
(266,900)
Balance
Cash
331,000
272,000
376,000
Long term investments
9,000
104,000
Excess cash
25,800
Stockholders' equity
3,000
2,318,000
2,329,000
Invested Capital
9,870,000
10,428,000
10,668,200
ROIC
5.40%
2.08%
5.87%
ROCE
7.08%
3.38%
6.09%
EV
Common stock shares outstanding
121,863
121,861
122,254
Price
Market cap
EV
EBITDA
699,000
1,285,000
1,402,000
EV/EBITDA
Interest
288,000
112,000
Interest/NOPBT
78.69%
16.49%